IVD Procedure Volumes and Pricing Analysis: Forecasts to 2019

Attention: There is an updated edition available for this report.
 
   Single User - $1,995
   Site License (one location, 10 users) - $2,995
   Corporate License - $3,995



Loading...
Published Jan 14, 2015 | 213 Pages | Pub ID: KLI5440452

This Kalorama Information report, IVD Procedure Volumes and Pricing Analysis, takes an informative look at worldwide procedure volumes for IVD  tests.  The report provides global 2014 sales  of equipment, reagents and other products related to in vitro diagnostic tests.  

Market estimates for each major market segment represent global revenues and are expressed in current dollars. Segments covered include:

Point-of-Care (OTC Total, Glucose, Pregnancy/ Ovulation, Other, Professional Total, Glucose, Infectious Disease, Critical Care, Other)
Molecular (Infectious Disease [inc. molecular tests for HIV, Hepatitis, STDs, HAI, Respiratory, Other], Oncology, Inherited Disease, Other)
Hematology
Coagulation (PT, PTT)
Microbiology (Automated Panels, Manual Panels, Blood Culture, Chromogenic Media)
Blood Banking
Core lab (General Chemistries, Blood Gas Analyzers, Urinalysis, Immunoassays Infectious Disease, Cardiac Markers, Diabetes/HbA1c, Autoimmune)
Histology/Cytology (Pap, Non-Pap, Image Cytometry, Flow Cytometry, ISH, IHC, CTCs)

There are several approaches to examining a market, the most prominent being sales analysis and procedure analysis (how many procedures performed).  Both are useful for business planners to construct models and size up opportunties in their field.  Pricing trend analysis is provided for each category. For each test type, estimates are provided for the historic 2014 period and forecasts are provided through 2019. Price estimates are offered for leading products, systems and equipment; these represent average list prices  


Diagnostic equipment has transformed in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, automation, miniaturization and microelectronics as well as rapid development and proliferation of novel telecommunications technologies. 

This report, IVD Procedure Volumes and Pricing Analysis is a one of a kind reprot that demonstrates to readers which companies are performing what share of IVD procedures in the market. The following IVD leaders are profiled and their procedure volumes are analyzed in this report:

Roche
Siemens
Spectra Laboratories
Sysmex Corp.
Thermo Fisher Scientific
Abbott Laboratories
ALERE
Arkray
Beckman Coulter, Inc./Danaher
Becton, Dickinson & Co.
bioMerieux, Inc.
Bio-RAD Laboratories, Inc.
Bio-Reference Laboratories
Genoptix, Inc./Novartis
Gen-Probe, Inc.
Hologic, Inc.
Horiba Medical
Instrumentation Laboratory
Laboratory Corporation of America
Myriad Genetics
Ortho Clinical Diagnostics
Qiagen
Quest Diagnostics
Radiometer A/S
Clarient, Inc./GE Healthcare
Danaher Corp.
DaVita, Inc.
 
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.